Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Source link
About The Author
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion